Lymphoma – Medxy AI

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap

By MedXY 08/20/2026

This review explores the Global Lymphoma Registry Alliance’s roadmap for leveraging multinational real-world data collaborations to address lymphoma’s heterogeneity, optimize treatment strategies, and improve patient outcomes worldwide through data harmonization, multi-stakeholder collaboration, and innovative registry integration.

Clinical Updates news

Comparative Safety and Efficacy of TEAM versus BEAM Conditioning Regimens in Autologous Transplantation for Lymphoma: A Comprehensive Review

By MedXY 08/15/2026

This review synthesizes evidence regarding the safety, efficacy, and clinical outcomes of TEAM versus BEAM conditioning regimens in autologous transplantation for lymphoma, integrating data from randomized trials and meta-analyses to inform optimal conditioning strategies.

Hematology-Oncology news Oncology

Targeting Ibrutinib Resistance Pathways with miR-28 in ABC-DLBCL

By MedXY 05/29/2026

miR-28 suppresses the emergence of ibrutinib resistance in ABC-DLBCL by disrupting clonal selection and dampening mitochondrial and mTOR signaling, with promising preclinical nanoparticle delivery results.

Hematology-Oncology Specialties

Venous Thromboembolism in Newly Diagnosed Lymphoma Patients: Insights from a Real-World Vietnamese Cohort

By MedXY 08/26/2025

An 8.3% incidence of VTE was observed in newly diagnosed lymphoma patients in Vietnam, with pretreatment elevated D-dimer and cardiovascular comorbidities as key risk factors, emphasizing the need for tailored thromboprophylaxis.